Quadrant Capital Group LLC Prothena Corp Public LTD CO Transaction History
Quadrant Capital Group LLC
- $1.42 Billion
- Q3 2024
A detailed history of Quadrant Capital Group LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Quadrant Capital Group LLC holds 1,383 shares of PRTA stock, worth $21,049. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,383
Previous 386
258.29%
Holding current value
$21,049
Previous $7,000
228.57%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding PRTA
# of Institutions
184Shares Held
42.7MCall Options Held
162KPut Options Held
102K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$176 Million8.41% of portfolio
-
Wellington Management Group LLP Boston, MA4.18MShares$63.6 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$58.7 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.82MShares$58.2 Million0.01% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.74MShares$26.5 Million4.0% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $714M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...